Progress in the development and acquisition of anticancer agents from marine sources.
Amador
M L
ML
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA. mamador2@jhmi.edu
Jimeno
J
J
Paz-Ares
L
L
Cortes-Funes
H
H
Hidalgo
M
M
D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology* / Q000627:therapeutic use*; D054713:Bryostatins; D017321:Clinical Trials, Phase I as Topic; D047630:Depsipeptides; D004149:Dioxoles / Q000494:pharmacology / Q000627:therapeutic use; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology / Q000627:therapeutic use; D007783:Lactones / Q000494:pharmacology / Q000627:therapeutic use; D018942:Macrolides; D008386:Marine Biology; D009369:Neoplasms / Q000188:drug therapy; D009842:Oligopeptides / Q000494:pharmacology / Q000627:therapeutic use; D010456:Peptides, Cyclic / Q000494:pharmacology / Q000627:therapeutic use; D044005:Tetrahydroisoquinolines; D000077606:Trabectedin
D018906:Antineoplastic Agents, Alkylating; D000972:Antineoplastic Agents, Phytogenic; D054713:Bryostatins; D047630:Depsipeptides; D004149:Dioxoles; D007546:Isoquinolines; D007783:Lactones; D018942:Macrolides; D009842:Oligopeptides; D010456:Peptides, Cyclic; D044005:Tetrahydroisoquinolines; C046785:bryostatin 1; C030051:didemnins; C064570:dolastatin 10; D000077606:Trabectedin